Trial Details
COMPLETEDBasic Information
| Clinical ID | c1315 |
|---|---|
| Identifier | NCT00408629 |
| Trial Title | Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: adalimumab|BIOLOGICAL: placebo |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-11-06 |
|---|---|
| Primary Completion Date | 2025-03-10 |
| Completion Date | 2025-03-10 |